J Korean Assoc Oral Maxillofac Surg.  2022 Jun;48(3):131-132. 10.5125/jkaoms.2022.48.3.131.

Post-acute infection syndrome after COVID-19: effects on the oral and maxillofacial region and the recent publication trends

• Park JY

• KMID: 2531048
• DOI: http://doi.org/10.5125/jkaoms.2022.48.3.131

Reference

References

1. World Health Organization (WHO). 2022. WHO coronavirus (COVID-19) dashboard [Internet]. Available from: https://covid19.who.int/.cited 2022 Jun 1.

2. Choutka J, Jansari V, Hornig M, Iwasaki A. 2022; Unexplained post-acute infection syndromes. Nat Med. 28:911–23. https://doi.org/10.1038/s41591-022-01810-6. DOI: 10.1038/s41591-022-01810-6. PMID: 35585196.

3. Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. 2021; Short-term and Long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 4:e2128568. https://doi.org/10.1001/jamanetworkopen.2021.28568. DOI: 10.1001/jamanetworkopen.2021.28568. PMID: 34643720. PMCID: PMC8515212.

4. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 2021; 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 397:220–32. https://doi.org/10.1016/S0140-6736(20)32656-8. DOI: 10.1016/S0140-6736(20)32656-8. PMID: 33428867. PMCID: PMC7833295.

5. Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. 2021; Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 18:e1003773. https://doi.org/10.1371/journal.pmed.1003773. DOI: 10.1371/journal.pmed.1003773. PMID: 34582441. PMCID: PMC8478214.

6. Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. 2006; ; Dubbo Infection Outcomes Study Group. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 333:575. https://doi.org/10.1136/bmj.38933.585764.AE. DOI: 10.1136/bmj.38933.585764.AE. PMID: 16950834. PMCID: PMC1569956.

7. Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, et al. 2021; Covid-19 breakthrough infections in vaccinated health care workers. N Engl J Med. 385:1474–84. https://doi.org/10.1056/NEJMoa2109072. DOI: 10.1056/NEJMoa2109072. PMID: 34320281. PMCID: PMC8362591.

8. Balushi AA, Ajmi AA, Sinani QA, Menon V, Berieki ZA, Shezawi AA, et al. 2022; COVID-19-associated mucormycosis: an opportunistic fungal infection. A case series and review. Int J Infect Dis. 121:203–10. https://doi.org/10.1016/j.ijid.2022.05.005. DOI: 10.1016/j.ijid.2022.05.005. PMID: 35533833. PMCID: PMC9075983.

9. Ali IE, Chugh A, Cheewin T, Hattori M, Sumita YI. 2022; The rising challenge of mucormycosis for maxillofacial prosthodontists in the Covid-19 pandemic: a literature review. J Prosthodont Res. https://doi.org/10.2186/jpr.JPR_D_21_00264 [Epub ahead of print]. DOI: 10.2186/jpr.JPR_D_21_00264. PMID: 35283402.

10. Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, et al. 2021; Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia. 186:289–98. https://doi.org/10.1007/s11046-021-00528-2. DOI: 10.1007/s11046-021-00528-2. PMID: 33544266. PMCID: PMC7862973.

11. Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. 2021; Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol. 135:442–7. https://doi.org/10.1017/S0022215121000992. DOI: 10.1017/S0022215121000992. PMID: 33827722. PMCID: PMC8060545.

12. Kumar M, Sarma DK, Shubham S, Kumawat M, Verma V, Singh B, et al. 2021; Mucormycosis in COVID-19 pandemic: risk factors and linkages. Curr Res Microb Sci. 2:100057. https://doi.org/10.1016/j.crmicr.2021.100057. DOI: 10.1016/j.crmicr.2021.100057. PMID: 34396355. PMCID: PMC8349419.

13. Bhargava D, Ahirwal R, Dubey S, Gurjar P, Pandey A, Beena S, et al. 2021; COVID induced functional exhaustion and persistently reduced lymphocytes as vital contributing factors for post-COVID rhino-orbital and cerebral mucormycosis in patients with diabetes: report from the Indian sub-continent. Head Neck Pathol . https://doi.org/10.1007/s12105-021-01382-w [Epub ahead of print]. DOI: 10.1007/s12105-021-01382-w. PMID: 34751896. PMCID: PMC8576088.

14. Al-Mahalawy H, El-Mahallawy Y, Dessoky NY, Ibrahim S, Amer H, Ayad HM, et al. 2022; Post-COVID-19 related osteonecrosis of the jaw (PC-RONJ): an alarming morbidity in COVID-19 surviving patients. BMC Infect Dis. 22:544. https://doi.org/10.1186/s12879-022-07518-9. DOI: 10.1186/s12879-022-07518-9. PMID: 35701730. PMCID: PMC9192922.

15. Fakhruddin KS, Samaranayake LP, Buranawat B, Ngo H. 2022; Oro-facial mucocutaneous manifestations of coronavirus disease-2019 (COVID-19): a systematic review. PLoS One. 17:e0265531. https://doi.org/10.1371/journal.pone.0265531. DOI: 10.1371/journal.pone.0265531. PMID: 35648785. PMCID: PMC9159624.

16. Gupta S, Saarikko M, Pfützner A, Räisänen IT, Sorsa T. 2022; Compromised periodontal status could increase mortality for patients with COVID-19. Lancet Infect Dis. 22:314. https://doi.org/10.1016/S1473-3099(22)00065-2. DOI: 10.1016/S1473-3099(22)00065-2. PMID: 35218744. PMCID: PMC8865881.

17. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. 2021; More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 11:16144. https://doi.org/10.1038/s41598-021-95565-8. DOI: 10.1038/s41598-021-95565-8. PMID: 34373540. PMCID: PMC8352980.

18. Mañón VA, Balandran S, Young S, Wong M, Melville JC. 2022; COVID-associated avascular necrosis of the maxilla-a rare, new side effect of COVID-19. J Oral Maxillofac Surg. https://doi.org/10.1016/j.joms.2022.04.015 [Epub ahead of print]. DOI: 10.1016/j.joms.2022.04.015. PMCID: PMC9072768. PMID: 35588767.

19. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. 2020; High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 12:8. https://doi.org/10.1038/s41368-020-0074-x. DOI: 10.1038/s41368-020-0074-x. PMID: 32094336. PMCID: PMC7039956.